FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012666603> ?p ?o ?g. }

• W3012666603 abstract "Abstract Background Many countries have made substantial progress in scaling-up and sustaining malaria intervention coverage, leading to more focalized and heterogeneous transmission in many settings. Evaluation provides valuable information for programmes to understand if interventions have been implemented as planned and with quality, if the programme had the intended impact on malaria burden, and to guide programmatic decision-making. Low-, moderate-, and heterogeneous-transmission settings present unique evaluation challenges because of dynamic and targeted intervention strategies. This paper provides illustration of evaluation approaches and methodologies for these transmission settings, and suggests how to answer evaluation questions specific to the local context. Methods The Roll Back Malaria Monitoring and Evaluation Reference Group formed a task force in October 2017 to lead development of this framework. The task force includes representatives from National Malaria Programmes, funding agencies, and malaria research and implementing partners. The framework builds on existing guidance for process and outcome evaluations and impact evaluations specifically in high transmission settings. Results The theory of change describes how evaluation questions asked by national malaria programmes in different contexts influence evaluation design. The transmission setting, existing stratification, and data quality and availability are also key considerations. The framework is intended for adaption by countries to their local context, and use for evaluation at sub-national level. Confirmed malaria incidence is recommended as the primary impact indicator due to its sensitivity to detect changes in low-transmission settings. It is expected that process evaluations provide sufficient evidence for programme monitoring and improvement, while impact evaluations are needed following adoption of new mixes of interventions, operational strategies, tools or policies, particularly in contexts of changing malaria epidemiology. Impact evaluations in low-, moderate-, or heterogeneous-transmission settings will likely use plausibility designs, and methods highlighted by the framework include interrupted time series, district-level dose–response analyses, and constructed control methods. Triangulating multiple data sources and analyses is important to strengthen the plausibility argument. Conclusions This framework provides a structure to assist national malaria programmes and partners to design evaluations in low-, moderate- or heterogeneous-transmission settings. Emphasizing a continuous cycle along the causal pathway linking process evaluation to impact evaluation and then programmatic decision-making, the framework provides practical guidance in evaluation design, analysis, and interpretation to ensure that the evaluation meets national malaria programme priority questions and guides decision-making at national and sub-national levels." @default.
• W3012666603 created "2020-03-27" @default.
• W3012666603 creator A5031514594 @default.
• W3012666603 creator A5035456375 @default.
• W3012666603 creator A5058620441 @default.
• W3012666603 creator A5065285916 @default.
• W3012666603 creator A5080534708 @default.
• W3012666603 date "2020-02-18" @default.
• W3012666603 modified "2023-10-18" @default.
• W3012666603 title "Evaluating malaria programmes in moderate- and low-transmission settings: practical ways to generate robust evidence" @default.
• W3012666603 cites W1593976993 @default.
• W3012666603 cites W1760554073 @default.
• W3012666603 cites W1778902010 @default.
• W3012666603 cites W1862419810 @default.
• W3012666603 cites W1892986689 @default.
• W3012666603 cites W1968518701 @default.
• W3012666603 cites W1978467899 @default.
• W3012666603 cites W1984963575 @default.
• W3012666603 cites W2052462306 @default.
• W3012666603 cites W2097208537 @default.
• W3012666603 cites W2120384759 @default.
• W3012666603 cites W2121584744 @default.
• W3012666603 cites W2126470212 @default.
• W3012666603 cites W2131091741 @default.
• W3012666603 cites W2137532217 @default.
• W3012666603 cites W2149473605 @default.
• W3012666603 cites W2157713798 @default.
• W3012666603 cites W2320400830 @default.
• W3012666603 cites W2342346817 @default.
• W3012666603 cites W2416547532 @default.
• W3012666603 cites W2546501775 @default.
• W3012666603 cites W2600481469 @default.
• W3012666603 cites W2624828354 @default.
• W3012666603 cites W2625919681 @default.
• W3012666603 cites W2744600822 @default.
• W3012666603 cites W2751191062 @default.
• W3012666603 cites W2756859181 @default.
• W3012666603 cites W2757058840 @default.
• W3012666603 cites W2757629837 @default.
• W3012666603 cites W2758125008 @default.
• W3012666603 cites W2759724644 @default.
• W3012666603 cites W2759735128 @default.
• W3012666603 cites W2760307091 @default.
• W3012666603 cites W2767125253 @default.
• W3012666603 cites W2780525796 @default.
• W3012666603 cites W2804789619 @default.
• W3012666603 cites W2883904009 @default.
• W3012666603 cites W2892705295 @default.
• W3012666603 cites W2896723125 @default.
• W3012666603 cites W2945557113 @default.
• W3012666603 cites W2950595532 @default.
• W3012666603 cites W2959677168 @default.
• W3012666603 cites W4214686509 @default.
• W3012666603 cites W6724819 @default.
• W3012666603 doi "https://doi.org/10.1186/s12936-020-03158-z" @default.
• W3012666603 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7027277" @default.
• W3012666603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32070357" @default.
• W3012666603 hasPublicationYear "2020" @default.
• W3012666603 type Work @default.
• W3012666603 sameAs 3012666603 @default.
• W3012666603 citedByCount "10" @default.
• W3012666603 countsByYear W30126666032020 @default.
• W3012666603 countsByYear W30126666032021 @default.
• W3012666603 countsByYear W30126666032022 @default.
• W3012666603 countsByYear W30126666032023 @default.
• W3012666603 crossrefType "journal-article" @default.
• W3012666603 hasAuthorship W3012666603A5031514594 @default.
• W3012666603 hasAuthorship W3012666603A5035456375 @default.
• W3012666603 hasAuthorship W3012666603A5058620441 @default.
• W3012666603 hasAuthorship W3012666603A5065285916 @default.
• W3012666603 hasAuthorship W3012666603A5080534708 @default.
• W3012666603 hasBestOaLocation W30126666031 @default.
• W3012666603 hasConcept C112930515 @default.
• W3012666603 hasConcept C144133560 @default.
• W3012666603 hasConcept C159110408 @default.
• W3012666603 hasConcept C166957645 @default.
• W3012666603 hasConcept C17744445 @default.
• W3012666603 hasConcept C195094911 @default.
• W3012666603 hasConcept C199539241 @default.
• W3012666603 hasConcept C203014093 @default.
• W3012666603 hasConcept C205649164 @default.
• W3012666603 hasConcept C27415008 @default.
• W3012666603 hasConcept C2778048844 @default.
• W3012666603 hasConcept C2779343474 @default.
• W3012666603 hasConcept C2780665704 @default.
• W3012666603 hasConcept C2780815959 @default.
• W3012666603 hasConcept C3116431 @default.
• W3012666603 hasConcept C41008148 @default.
• W3012666603 hasConcept C5395021 @default.
• W3012666603 hasConcept C71924100 @default.
• W3012666603 hasConcept C761482 @default.
• W3012666603 hasConcept C76155785 @default.
• W3012666603 hasConceptScore W3012666603C112930515 @default.
• W3012666603 hasConceptScore W3012666603C144133560 @default.
• W3012666603 hasConceptScore W3012666603C159110408 @default.
• W3012666603 hasConceptScore W3012666603C166957645 @default.
• W3012666603 hasConceptScore W3012666603C17744445 @default.
• W3012666603 hasConceptScore W3012666603C195094911 @default.
• W3012666603 hasConceptScore W3012666603C199539241 @default.
• W3012666603 hasConceptScore W3012666603C203014093 @default.

• next